Pfizer and GlaxoSmithKline may lose contracts for supplies of vaccines to Russia

Natsimbio, a subsidiary of Russia’s state corporation Rostec has signed an agreement with Serum Institute of India, one of India’s largest producers of vaccines, on the localization of production of a number of vaccines in Russia, according to an official spokesman of Rostec, reports The Pharma Letter’s local correspondent.

The project involves the launch of production of vaccines against polio, pneumococcus and Haemophilus influenzae, as well as a number of other drugs.

According to Nikolai Semyonov, chief executive of Natsimbio, production will be launched at one of the plants of the company.